Back to Screener

Aptorum Group Limited Class A Ordinary Shares (APM)

Price$1.01
Value ScoreC
Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-30.05%
Price vs S&P 500 (4W)26.27%
VGM Score56.88
Market Capitalization$8.23M

All Metrics

Book Value / Share (Quarterly)$2.84
P/TBV (Annual)0.37x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.23
Price vs S&P 500 (YTD)-8.19%
Gross Margin (TTM)7.10%
Net Profit Margin (TTM)-1115.14%
EPS (TTM)$-0.35
10-Day Avg Trading Volume0.19M
EPS Excl Extra (TTM)$-0.35
EPS (Annual)$-0.19
ROI (Annual)-5.11%
Gross Margin (Annual)2.45%
Net Profit Margin (5Y Avg)-1143.89%
Cash / Share (Quarterly)$0.42
ROA (Last FY)-7.29%
EBITD / Share (TTM)$-0.24
ROE (5Y Avg)-41.19%
Operating Margin (TTM)-1298.41%
Cash Flow / Share (Annual)$-0.23
P/B Ratio0.36x
P/B Ratio (Quarterly)0.37x
Net Income / Employee (Annual)$-1,363,300
EV / Revenue (TTM)6.88x
Net Interest Coverage (TTM)-4.53x
ROA (TTM)-12.07%
EPS Incl Extra (Annual)$-0.19
Current Ratio (Annual)0.78x
Quick Ratio (Quarterly)0.77x
3-Month Avg Trading Volume0.07M
52-Week Price Return-8.40%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.84
P/S Ratio (Annual)19.07x
Asset Turnover (Annual)0.02x
52-Week High$4.47
Operating Margin (5Y Avg)-2091.41%
EPS Excl Extra (Annual)$-0.19
Tangible BV CAGR (5Y)-10.74%
26-Week Price Return-18.66%
Quick Ratio (Annual)0.77x
13-Week Price Return31.96%
Total Debt / Equity (Annual)0.15x
Current Ratio (Quarterly)0.78x
Enterprise Value$8.27M
Asset Turnover (TTM)0.07x
Book Value / Share Growth (5Y)9.92%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)28.05x
Pretax Margin (Annual)-1006.30%
Cash / Share (Annual)$0.42
3-Month Return Std Dev101.66%
Gross Margin (5Y Avg)-9.07%
Net Income / Employee (TTM)$-2,065,800
ROE (Last FY)-5.89%
Net Interest Coverage (Annual)-14.59x
EPS Basic Excl Extra (Annual)$-0.19
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.15x
EPS Incl Extra (TTM)$-0.35
Receivables Turnover (Annual)3.96x
ROI (TTM)-8.10%
P/S Ratio (TTM)6.85x
Pretax Margin (5Y Avg)-1367.78%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.84
Forward P/E0.33x
Price vs S&P 500 (52W)-35.45%
Year-to-Date Return2.83%
5-Day Price Return5.83%
EPS Normalized (Annual)$-0.19
ROA (5Y Avg)-41.75%
Net Profit Margin (Annual)-654.79%
Month-to-Date Return5.83%
Cash Flow / Share (TTM)$-2.89
EBITD / Share (Annual)$-0.25
Operating Margin (Annual)-2486.03%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-36.51%
LT Debt / Equity (Quarterly)0.14x
EPS Basic Excl Extra (TTM)$-0.35
P/TBV (Quarterly)0.37x
P/B Ratio (Annual)0.37x
Inventory Turnover (TTM)28.05x
Pretax Margin (TTM)-1282.26%
Book Value / Share (Annual)$2.84
Price vs S&P 500 (13W)21.46%
Beta0.01x
Revenue / Share (TTM)$0.00
ROE (TTM)-9.33%
52-Week Low$0.65
vGradeC
mGradeB
vgmGradeC
Show chart for

Analyst Recommendations

Jun 2023
Jul 2023
Aug 2023
Sep 2023
4.00
4.00
4.00
4.00

Industry Peers — Measuring & Controlling Devices(10)

About

Aptorum Group develops clinical-stage therapeutics targeting oncology and infectious diseases, with emphasis on orphan cancer indications where treatment options are limited. Its pipeline includes ALS-4, SACT-1, and RPIDD programs, supported by healthcare services operations.